Valuation: Guizhou Bailing Group Pharmaceutical Co., Ltd.

Market Cap 6.28B 934M 802M 752M 687M 1.3B 89.07B 1.3B 8.9B 3.45B 44.94B 3.51B 3.43B 149B P/E 2024
193x
P/E 2025 -54.4x
Enterprise Value 7.15B 1.06B 913M 857M 783M 1.48B 101B 1.48B 10.14B 3.93B 51.2B 3.99B 3.91B 170B EV / Sales 2024
1.74x
EV / Sales 2025 2.23x
Free-Float
67.53%
Yield 2024 *
-
Yield 2025 -
1 day+0.66%
1 week+0.44%
Current month-0.43%
1 month+3.85%
3 months-1.29%
6 months-1.29%
Current year+5.29%
1 week 4.44
Extreme 4.44
4.64
1 month 4.36
Extreme 4.36
4.85
Current year 4.08
Extreme 4.08
5.47
1 year 4.08
Extreme 4.08
6.43
3 years 2.98
Extreme 2.98
8.8
5 years 2.98
Extreme 2.98
11.97
10 years 2.98
Extreme 2.98
25.12
Manager TitleAgeSince
Chief Executive Officer 56 01/04/2015
Director of Finance/CFO 41 28/12/2020
Corporate Officer/Principal 42 26/01/2014
Director TitleAgeSince
Chairman 56 26/03/2026
Director/Board Member 58 24/12/2007
Director/Board Member 42 26/01/2014
Date Insider Type Main position Quantity % Market Cap.
21/09/20 Sell

Chairman

1,940,600 0.2495%
18/09/20 Sell

Director

3,670,000 0.4719%
18/09/20 Sell

Chairman

296,500 0.0381%
Change 5-day change 1-year change 3-year change Capi.($)
+0.66%+0.44%-26.72%-39.82% 930M
+1.01%+1.01%-13.78%-5.57% 13.27B
+1.98%+0.33%-35.14%-57.05% 4.95B
+1.85%-5.05%-6.75%-2.34% 4.64B
+1.58%-4.23%-1.29%-28.74% 4B
+1.01%+0.61%-21.17%+5.44% 3.57B
+2.21%+3.87%-6.13%-3.71% 3.42B
-0.47%-4.16%-13.69%+11.83% 3.28B
+0.86%-3.04%-19.63%-15.55% 2.4B
+1.82%-1.23%-31.46%-11.34% 1.69B
Average +1.25%-0.74%-17.58%-14.69% 4.22B
Weighted average by Cap. +1.27%-0.75%-15.66%-12.58%

Financials

2024 2025
Net sales 3.83B 569M 488M 458M 419M 790M 54.27B 794M 5.42B 2.1B 27.38B 2.14B 2.09B 90.68B 3.05B 453M 389M 365M 334M 630M 43.25B 633M 4.32B 1.68B 21.82B 1.7B 1.67B 72.26B
Net income 33.62M 5M 4.29M 4.03M 3.68M 6.94M 477M 6.98M 47.67M 18.48M 241M 18.78M 18.37M 797M -104M -15.52M -13.32M -12.5M -11.42M -21.55M -1.48B -21.66M -148M -57.35M -747M -58.28M -57.02M -2.47B
Net Debt 1.4B 208M 179M 168M 153M 289M 19.86B 291M 1.99B 770M 10.02B 782M 765M 33.19B 875M 130M 112M 105M 95.72M 181M 12.41B 182M 1.24B 481M 6.26B 488M 478M 20.73B
Logo Guizhou Bailing Group Pharmaceutical Co., Ltd.
Guizhou Bailing Group Pharmaceutical Co Ltd is a China-based company principally engaged in the research and development, production and sales of Miao medicine. The Company operates four segments. The Industrial segment is mainly engaged in the research and development, production and sales of Chinese patent medicine tablets, capsules and syrups. The Commercial segment is mainly engaged in drug distribution and big health business. The Medical Institution segment mainly operates diabetes hospitals. Other segment mainly provides Chinese medicinal materials and are engaged in organic fertilizer manufacturing, water production and supply and other businesses. The Company's products include Yindan Xinnaotong soft capsules, Kesuting syrup and capsules, Shuangyang Houbitong granules and non-Miao medicine products Jingan capsules, Vitamin C Yinqiao tablets, Xiaoer Chaigui antipyretic granules and other products. The Company mainly conducts its businesses in the domestic market.
Employees
5,715
Date Price Change Volume
26/08/26 CN¥4.600 +0.44% 6,439,184
25/08/26 CN¥4.580 +0.66% 6,025,884
24/08/26 CN¥4.550 +0.66% 7,148,984
21/08/26 CN¥4.520 0.00% 5,323,250
20/08/26 CN¥4.520 +1.12% 7,437,500

Annual profits - Rate of surprise

  1. Stock Market
  2. Stocks
  3. 002424 Stock